Not applicableEnded earlyNCT01757496What this trial is testingCough Assist in BronchiolitisWho this might be right forBronchiolitisRespiratory Syncytial Virus University Hospital, Antwerp 1
Early research (Phase 1)Study completedNCT02830932What this trial is testingDose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)Who this might be right forRespiratory Syncytial Virus (RSV) Vaxart 66
Not applicableStudy completedNCT00263900What this trial is testingTGV:Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency UnitWho this might be right forInfluenzaRespiratory Syncytial Viruses University Hospital, Rouen 377
Early research (Phase 1)Study completedNCT06601192What this trial is testingInvestigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy AdultsWho this might be right forRSV InfectionQTc Interval Enanta Pharmaceuticals, Inc 72
Testing effectiveness (Phase 2)Looking for participantsNCT07214571What this trial is testingS-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe DiseaseWho this might be right forRespiratory Syncytial Virus Infections Shionogi 192
Not applicableStudy completedNCT01922648What this trial is testingRSV Observational Study 2Who this might be right forRespiratory Syncytial Virus Infections University of Oxford 35
Testing effectiveness (Phase 2)Looking for participantsNCT06817889What this trial is testingRemdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised IndividualsWho this might be right forHematopoietic and Lymphatic System NeoplasmAutoimmune DiseaseRespiratory Syncytial Virus Infection Fred Hutchinson Cancer Center 60
Early research (Phase 1)Study completedNCT06573281What this trial is testingA Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 YearsWho this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 213
Testing effectiveness (Phase 2)Study completedNCT02266628What this trial is testingPlacebo- Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Elderly AdultsWho this might be right forRespiratory Syncytial Virus (RSV) Novavax 1,599
Large-scale testing (Phase 3)Looking for participantsNCT06775405What this trial is testingConfirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized InfantsWho this might be right forRespiratory Synctial Virus Infections Shanghai Ark Biopharmaceutical Co., Ltd. 180
Not applicableStudy completedNCT06424795What this trial is testingMolecular and Microbiome/Metagenome Correlates of Recurrent Wheeze in RSV Infected InfantsWho this might be right forRespiratory Syncytial Virus Infection University of Rochester 100
Not applicableActive Not RecruitingNCT06813872What this trial is testingEffectiveness of ABRYSVO® Maternal Respiratory Syncytial Virus (RSV) Vaccine Against RSV in Infants in Western PennsylvaniaWho this might be right forRespiratory Syncytial Viruses Pfizer 1
Not applicableStudy completedNCT03614676What this trial is testingOutcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV SurveillanceWho this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 4,493
Testing effectiveness (Phase 2)Study completedNCT06143046What this trial is testingMRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated MothersWho this might be right forRespiratory Syncytial Virus ModernaTX, Inc. 360
Not applicableUnknownNCT04925310What this trial is testingInfection With Respiratory Syncytial Virus in InfantsWho this might be right forRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus (RSV)Respiratory Syncytial Virus-bronchiolitis Hannover Medical School 350
Not applicableUnknownNCT05765838What this trial is testingCombined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens.Who this might be right forInfluenzaCOVID-19RSV Infection Rigshospitalet, Denmark 250
Testing effectiveness (Phase 2)Study completedNCT04138056What this trial is testingA Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant WomenWho this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 509
Not applicableUnknownNCT02519803What this trial is testingA Prospective Household Observational Cohort Study of Influenza, Respiratory Syncytial Virus and Other Respiratory Pathogens Community Burden and Transmission Dynamics in South AfricaWho this might be right forInfective Organism Causing Respiratory Diseaseand Meningitis National Institute for Communicable Diseases, South Africa 4,500
Testing effectiveness (Phase 2)Study completedNCT05687279What this trial is testingStudy on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)Who this might be right forRespiratory Syncytial Virus Infection Sanofi Pasteur, a Sanofi Company 80
Early research (Phase 1)Study completedNCT04519073What this trial is testingPhase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial VirusWho this might be right forAcute Bronchiolitis Due to Respiratory Syncytial Virus Virometix 60